ARDX Earnings — Ardelyx, Inc. Post-ER Performance | BigEarnings
ARDX — Ardelyx, Inc.
XNAS · Healthcare · Biotechnology
Price$6.04
Market Cap$1.5B
P/E—
52W Range$3.49 – $8.40
Next Earnings2026-08-03
About Ardelyx, Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
